Business Description
MediciNova is a US-based pharmaceutical company focused on creating new oral treatments for serious illnesses that currently have few or no effective options. Its two lead drug candidates, ibudilast and tipelukast, are both in Phase 2 clinical trials targeting a range of conditions including multiple sclerosis, ALS, liver disease, and certain cancers. Founded in 2000 and based in La Jolla, California, the company continues to build its pipeline around small molecule compounds that can be taken by mouth.
